Published in Orphanet J Rare Dis on November 15, 2011
IL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A Therapies. J Invest Dermatol (2015) 0.81
Novel STAT3 mutation causing hyper-IgE syndrome: studies of the clinical course and immunopathology. J Clin Immunol (2014) 0.79
A Case of Hyper Immunoglobulin-E Syndrome Associated with Scrotal Tongue and Intraoral Hyperpigmentation. Indian J Dermatol (2015) 0.78
Cancers Related to Immunodeficiencies: Update and Perspectives. Front Immunol (2016) 0.75
Recurrent Skin and Lung Infections in Autosomal Dominant Hyper IgE Syndrome with Transactivation Domain STAT3 Mutation. Case Reports Immunol (2014) 0.75
STAT3 mutations in the hyper-IgE syndrome. N Engl J Med (2007) 8.99
Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature (2008) 8.17
Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature (2007) 7.07
Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. N Engl J Med (1999) 5.82
Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity (2006) 4.75
Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med (2009) 4.52
Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics (1972) 3.75
Job's Syndrome. Recurrent, "cold", staphylococcal abscesses. Lancet (1966) 3.27
Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol (2009) 3.13
Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet (1999) 2.63
Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol (2008) 2.50
An overview of IL-17 function and signaling. Cytokine (2008) 2.38
The hyper-IgE syndromes. Immunol Allergy Clin North Am (2008) 2.19
Abnormalities in the regulation of human IgE synthesis. Immunol Rev (1978) 2.14
Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr (2004) 2.01
Raised serum-IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections. Lancet (1974) 1.98
Hyper-IgE syndromes. Immunol Rev (2005) 1.92
Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol (2007) 1.61
Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent "cold" staphylococcal abscesses. Lancet (1974) 1.56
Systemic lupus erythematosus complicating hyper IgE syndrome. Br J Rheumatol (1997) 1.55
Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome. J Allergy Clin Immunol (2009) 1.49
Staphylococcal IgE antibodies, hyperimmunoglobulinemia E and Staphylococcus aureus infections. N Engl J Med (1979) 1.47
The hyper-IgE syndrome. Two cases and review of the literature. Int J Dermatol (2001) 1.44
Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation. Bone Marrow Transplant (2010) 1.38
Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes. Pediatr Res (2009) 1.36
Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol (2010) 1.36
Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation. Klin Padiatr (2010) 1.34
The hyper-IgE syndrome. Clin Rev Allergy Immunol (2001) 1.31
Bone marrow transplantation does not correct the hyper IgE syndrome. Bone Marrow Transplant (2000) 1.30
The hyperimmunoglobulin E recurrent-infection (Job's) syndrome. A review of the NIH experience and the literature. Medicine (Baltimore) (1983) 1.28
Genetic, clinical, and laboratory markers for DOCK8 immunodeficiency syndrome. Dis Markers (2010) 1.28
New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome. Mucosal Immunol (2011) 1.26
Dedicator of cytokinesis 8 (DOCK8) deficiency. Curr Opin Allergy Clin Immunol (2010) 1.24
Successful engraftment of donor marrow after allogeneic hematopoietic cell transplantation in autosomal-recessive hyper-IgE syndrome caused by dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol (2010) 1.24
Ophthalmic complications including retinal detachment in hyperimmunoglobulinemia E (Job's) syndrome: Case report and review of literature. Indian J Ophthalmol (2009) 1.24
Delayed eruption of permanent teeth in hyperimmunoglobulinemia E recurrent infection syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2000) 1.21
Hyperimmunoglobulin-E syndrome with recurrent infection: a review of current opinion and treatment. Pediatr Allergy Immunol (2000) 1.20
TH17 cells and regulatory T cells in primary immunodeficiency diseases. J Allergy Clin Immunol (2009) 1.18
Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma. Proc Natl Acad Sci U S A (1989) 1.18
Non-Hodgkin's lymphoma in Job's syndrome: a case report and literature review. Leuk Lymphoma (2004) 1.17
The hyperimmunoglobulin E syndrome--a neutrophil chemotactic defect reversible by histamine H2 receptor blockade? Clin Immunol Immunopathol (1980) 1.17
IgE antibodies to Staphylococcus aureus and Candida albicans in patients with the syndrome of hyperimmunoglobulin E and recurrent infections. J Immunol (1980) 1.16
Coronary artery aneurysms in patients with hyper IgE recurrent infection syndrome. Clin Immunol (2006) 1.14
Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency. Int Immunol (2008) 1.12
Increased in vitro bone resorption by monocytes in the hyper-immunoglobulin E syndrome. J Immunol (1988) 1.11
Cytokine-mediated bone resorption in patients with the hyperimmunoglobulin E syndrome. Clin Immunol Immunopathol (1995) 1.07
The face of Job. J Pediatr (1998) 1.05
Cranial synostosis in Job's syndrome. Lancet (1978) 1.04
Pneumocystis jiroveci infection in patients with hyper-immunoglobulin E syndrome. Pediatrics (2006) 1.04
Clinical and immunologic aspects of the hyperimmunoglobulin E syndrome. Hematol Oncol Clin North Am (1988) 1.03
Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. J Allergy Clin Immunol (2010) 1.03
Hyper-IgE syndrome and H2-receptor blockade. Lancet (1989) 1.02
Hyperimmunoglobulin E syndrome: two cases and a review of the literature. J Am Acad Dermatol (2006) 1.02
Esophageal cryptococcosis in a patient with the hyperimmunoglobulin E-recurrent infection (Job's) syndrome. Gastroenterology (1984) 1.00
High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome. Ann Allergy Asthma Immunol (1998) 1.00
High-dose intravenous gamma-globulin treatment for hyperimmunoglobulinemia E syndrome. J Allergy Clin Immunol (1995) 0.98
Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome. J Allergy Clin Immunol (2010) 0.98
Eye involvement in hyperimmunoglobulinemia E (Job's) syndrome. J Pediatr Ophthalmol Strabismus (2001) 0.97
Effects of allogeneic peripheral stem cell transplantation in a patient with job syndrome of hyperimmunoglobulinemia E and recurrent infections. Am J Med (1998) 0.97
Pneumatocele complicating hyperimmunoglobulin E syndrome (Job's Syndrome). Ann Thorac Surg (1992) 0.97
Immunoglobulin E anti-Staphylococcus aureus antibodies in atopic patients. J Clin Microbiol (1981) 0.96
Coronary artery abnormalities in Hyper-IgE syndrome. J Clin Immunol (2011) 0.95
Craniosynostosis in hyper-IgE-syndrome. Eur J Pediatr (1985) 0.94
Systemic lupus erythematosus in Staphylococcus aureus hyperimmunoglobulinaemia E syndrome. Br Med J (Clin Res Ed) (1983) 0.94
Severe periodontitis in a 5-year-old girl with hyperimmunoglobulin E syndrome. Pediatr Dent (2005) 0.93
The development of pulmonary adenocarcinoma in a patient with Job's syndrome, a rare immunodeficiency condition. Tumori (2004) 0.92
Dermatitis and the newborn rash of hyper-IgE syndrome. Arch Dermatol (2004) 0.92
A review on the vascular features of the hyperimmunoglobulin E syndrome. Clin Exp Immunol (2009) 0.90
Ileocecal histoplasmosis mimicking Crohn's disease in a patient with Job's syndrome. Digestion (1986) 0.89
Fatal histiocytic lymphoma of the brain associated with hyperimmunoglobulinemia-E and recurrent infections. Cancer (1977) 0.88
Genetic origins of hyper-IgE syndrome. Curr Allergy Asthma Rep (2008) 0.88
Hyperimmunoglobulinemia E syndrome: association with osteoporosis and recurrent fractures. Radiology (1985) 0.87
Cutaneous manifestations of hyper-IgE syndrome in infants and children. J Pediatr (2002) 0.87
Hyper IgE syndrome: report of two cases with moderate elevation of IgE. Indian J Dermatol Venereol Leprol (2006) 0.86
A boy with recurrent infections, impaired PMN-chemotaxis, increased IgE concentrations and cranial synostosis--a variant of the hyper-IgE syndrome? Helv Paediatr Acta (1987) 0.85
T lymphocyte dysfunction, hyperimmunoglobulinemia E, recurrent bacterial infections, and defective neutrophil chemotaxis in a Negro child. J Pediatr (1976) 0.85
Job's syndrome: a rare cause of recurrent lung abscess in childhood. Ann Thorac Surg (1990) 0.85
Use of Antifungal Combination Therapy: Agents, Order, and Timing. Curr Fungal Infect Rep (2010) 0.85
Hyper immunoglobulin-E syndrome: a case with chronic ear draining mimicking polypoid otitis media. Int J Pediatr Otorhinolaryngol (2003) 0.84
Hodgkin's disease in a child with hyperimmunoglobulin E syndrome. Pediatr Hematol Oncol (1999) 0.84
Recurrent colonic histoplasmosis after standard therapy with amphotericin B in a patient with Job's syndrome. Am J Gastroenterol (1991) 0.84
Discordance for systemic lupus erythematosus and hyper IgE syndrome in a pair of monozygotic twins. Br J Rheumatol (1998) 0.83
Immunoglobulin E in primary immunodeficiency diseases. Allergy (2002) 0.82
Previously undiagnosed hyper-IgE syndrome in an adult with multiple systemic fungal infections. J Allergy Clin Immunol (1996) 0.82
Hodgkin lymphoma developing in a 4.5-year-old girl with hyper-IgE syndrome. Pediatr Hematol Oncol (2005) 0.81
Disseminated pulmonary candidiasis complicating hyperimmunoglobulin E (Job's) syndrome. J Thorac Imaging (2004) 0.81
A case of hyper-IgE syndrome complicated by cutaneous, nodal, and liver peripheral T cell lymphomas. J Dermatol (2002) 0.81
Use of recombinant human interferon gamma to enhance neutrophil chemotactic responses in Job syndrome of hyperimmunoglobulinemia E and recurrent infections. J Pediatr (1991) 0.81
Life-threatening cervicofacial infection in a child with hyperimmunoglobulin-E syndrome. J Oral Maxillofac Surg (2001) 0.81
Levamisole is inferior to placebo in the hyperimmunoglobulin E recurrent-infection (Job's) syndrome. N Engl J Med (1982) 0.81
Cyclosporin A in hyperimmunoglobulin E syndrome. Ann Allergy Asthma Immunol (1997) 0.81
Atopic dermatitis or hyper-IgE syndrome? Allergy Asthma Proc (2006) 0.80
Variant of hyper-IgE syndrome: the differentiation from atopic dermatitis is important because of treatment and prognosis. Dermatologica (1991) 0.79
Disseminated cryptococcal infection in a patient with hyperimmunoglobulinemia E syndrome. J Pediatr (1990) 0.78
Efficacy of long-term sulfamethoxazole-trimethoprim therapy in a boy with hyperimmunoglobulin E syndrome. Tohoku J Exp Med (1998) 0.77
Hyperimmunoglobin E syndrome: a sign of TH1/TH2 imbalance? Eur J Dermatol (1999) 0.77
Recombinant IFN-gamma treatment of a patient with hyperimmunoglobulin E syndrome triggered autoimmune thrombocytopenia. J Interferon Cytokine Res (1998) 0.76
Disseminated Bacillus Calmette-Guérin infection in a girl with hyperimmunoglobulin E syndrome. Acta Paediatr (1998) 0.76
Giant chalazia in the hyperimmunoglobulinemia E (hyper-IgE) syndrome. Eur J Ophthalmol (2004) 0.76
Remission of hyper-IgE syndrome treated with plasmapheresis and cytotoxic immunosuppression. J Clin Apher (1988) 0.76
Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) (2010) 2.33
Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol (2010) 1.36
Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood. J Exp Med (2012) 1.35
Cryptosporidium infection in patients with primary immunodeficiencies. J Pediatr Gastroenterol Nutr (2007) 1.08
[Health-related quality of life in children with Hymenoptera venom allergy treated with VIT and quality of life of their parents]. Przegl Lek (2010) 0.91
[Adaptation of Vespide Allergy Quality of Life Questionnaire for Polish children with venom allergy and for their parents]. Przegl Lek (2010) 0.90
Pulmonary lymphomatoid granulomatosis in Griscelli syndrome type 2. Viral Immunol (2011) 0.85
Are genes associated with energy metabolism important in asthma and BMI? J Asthma (2009) 0.85
Association analysis of brain-derived neurotrophic factor gene polymorphisms in asthmatic children. Pediatr Allergy Immunol (2007) 0.83
Nijmegen breakage syndrome: Long-term monitoring of viral and immunological biomarkers in peripheral blood before development of malignancy. Clin Immunol (2010) 0.82
Fatal respiratory distress syndrome due to coronavirus infection in a child with severe combined immunodeficiency. Influenza Other Respir Viruses (2012) 0.81
Oral findings in patients with Nijmegen breakage syndrome: a preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2009) 0.80
Common variable immune deficiency in children--clinical characteristics varies depending on defect in peripheral B cell maturation. J Clin Immunol (2013) 0.79
Oral manifestations of primary immune deficiencies in children. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2009) 0.79
Treosulfan-based conditioning regimen in a second matched unrelated peripheral blood stem cell transplantation for a pediatric patient with CGD and invasive aspergillosis, who experienced initial graft failure after RIC. Int J Hematol (2009) 0.79
Association analysis of tyrosine kinase FYN gene polymorphisms in asthmatic children. Int Arch Allergy Immunol (2007) 0.79
Developmental Enamel Defects of the Permanent First Molars and Incisors and Their Association with Dental Caries in the Region of Wielkopolska, Western Poland. Oral Health Prev Dent (2015) 0.78
Genotyping of Cryptosporidium isolates from human clinical cases in Poland. Parasitol Res (2008) 0.78
Toll-like receptor stimulation induces higher TNF-alpha secretion in peripheral blood mononuclear cells from patients with hyper IgE syndrome. Int Arch Allergy Immunol (2008) 0.78
[Diagnosis and venom specific immunotherapy (VIT) in allergic children in Poland--how much the current practice follows the international guidelines?]. Przegl Lek (2010) 0.77
[Increasing prevalence of asthma in school children--ISAAC study (International Study of Asthma and Allergies in Children)]. Pneumonol Alergol Pol (2003) 0.77
[Association of A/T polymorphism of the CHRM2 gene with bronchodilator response to ipratropium bromide in asthmatic children]. Pneumonol Alergol Pol (2009) 0.77
[Differences in the head and body structure among children with the ataxia-telangiectasia syndrome]. Pediatr Endocrinol Diabetes Metab (2009) 0.76
Neutrophil phenotypic characteristics in children with congenital asplenia and splenectomized for hereditary spherocytosis. Immunol Invest (2011) 0.75
[Educational program for doctors and nurses taking care for primary immunodeficiency patients treated with subcutaneous immunoglobulins]. Pol Merkur Lekarski (2011) 0.75
[The prevalence of allergic rhinitis and conjunctivitis in school children from Kraków and Poznań--ISAAC study (International Study of Asthma and Allergies in Childhood)]. Otolaryngol Pol (2004) 0.75
[Analysis of incidence and clinical picture of pneumothorax in children]. Pol Merkur Lekarski (2011) 0.75
[Is body mass index associated with asthma in children?]. Pneumonol Alergol Pol (2008) 0.75
[Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part II. Safety aspects of therapy with fluticasone propionate in asthmatic children]. Pol Merkur Lekarski (2004) 0.75
Acid steatocrit determination is not helpful in cystic fibrosis patients without or with mild steatorrhea. Pediatr Pulmonol (2010) 0.75
[Interstitial lung disease in the course of the surfactant protein C deficiency coexisting with the primary humoral immunodeficiency - case study]. Pneumonol Alergol Pol (2010) 0.75
[Chronic neutropenia - experience from the Department of Immunology, Children's Memorial Health Institute]. Med Wieku Rozwoj (2007) 0.75
[Use of stimulants among dental students]. Przegl Lek (2014) 0.75
Peripheral blood T lymphocyte subsets in children with congenital asplenia. Hum Immunol (2012) 0.75
[Clinical application of pulmonary function tests in preschool children]. Pneumonol Alergol Pol (2010) 0.75
[Haemophilus influenzae type b--active prevention]. Med Wieku Rozwoj (2009) 0.75
[Diagnosis and treatment of aspergillosis in the patients with chronic granulomatous disease]. Przegl Epidemiol (2006) 0.75
[Interstitial lung disease associated with surfactant protein B and C deficiencies]. Pneumonol Alergol Pol (2010) 0.75
[Conditions for use of stimulants assessed by medical university students]. Przegl Lek (2015) 0.75
Changes in the bronchial epithelia in patients with immotile cilia syndromes. Folia Morphol (Warsz) (2003) 0.75
[Hyper-IgE syndrome with mutation in STAT3 gene - case report and literature review]. Med Wieku Rozwoj (2009) 0.75
[Radiographic presentation of the bronchial and pulmonary changes in children with selected primary immunodeficiencies]. Pneumonol Alergol Pol (2007) 0.75
[Prevention of infections in primary and secondary antibody deficiency]. Przegl Epidemiol (2009) 0.75
[Techniques for assessing respiratory function in preschool children]. Pneumonol Alergol Pol (2010) 0.75
[Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma]. Pol Merkur Lekarski (2004) 0.75